Richard D and Katherine M O'Connor Research Professor of Alzheimer's Disease
Professor of Neurology
Co-Division Chief Cognitive Disorders
Department of Neurology
2901 Hubbard Road, Suite 2723
Ann Arbor, MI 48109
2901 Hubbard Road, Suite 2723
Ann Arbor, MI 48109
Available to mentor
Judith L Heidebrink
Clinical Professor
-
Oka T, Matsuzawa Y, Tsuneyoshi M, Nakamura Y, Aoshima K, Tsugawa H, Alzheimer’s Disease Metabolomics Consortium . Sci Rep, 2024 Apr 2; 14 (1): 6797Journal ArticleMultiomics analysis to explore blood metabolite biomarkers in an Alzheimer's Disease Neuroimaging Initiative cohort.
DOI:10.1038/s41598-024-56837-1 PMID: 38565541 -
Gierzynski TF, Gregoire A, Reader JM, Pantis R, Campbell S, Bhaumik A, Rahman-Filipiak A, Heidebrink J, Giordani B, Paulson H, Hampstead BM. J Int Neuropsychol Soc, 2024 Feb; 30 (2): 183 - 193.Journal ArticleEvaluation of the Uniform Data Set version 3 teleneuropsychological measures.
DOI:10.1017/S1355617723000383 PMID: 37366070 -
Heidebrink JL, Paulson HL. Annu Rev Med, 2024 Jan 29; 75: 99 - 111.Journal ArticleLessons Learned from Approval of Aducanumab for Alzheimer's Disease.
DOI:10.1146/annurev-med-051022-043645 PMID: 38285515 -
Guduguntla BA, Vasbinder A, Anderson E, Azam TU, Blakely P, Webster NJ, Gonzalez R, Atonucci T, Heidebrink JL, Giordani B, Zahodne L, Hampstead BM, Ajrouch KJ, Hayek SS. Alzheimers Dement (Amst), 2024 16 (1): e12568Journal ArticleBiomarkers of chronic inflammation and cognitive decline: A prospective observational study.
DOI:10.1002/dad2.12568 PMID: 38532827 -
Large Group Publications ADNI. More than 3000 peer-reviewed journal articles as of current year, 2024 Jan;Journal ArticleI am a site principal investigator and steering committee member for the Alzheimer's Disease Neuroimaging Initiative (ADNI) collaborative study. As such, I have participated in the study design, implementation, and data collection continuously since 2004. ADNI data are publicly available to all qualified investigators for analysis and publication.
-
Kirn DR, Grill JD, Aisen P, Ernstrom K, Gale S, Heidebrink J, Jicha G, Jimenez-Maggiora G, Johnson L, Peskind E, McCann K, Shaffer E, Sultzer D, Wang S, Sperling R, Raman R. Alzheimers Res Ther, 2023 May 2; 15 (1): 88Journal ArticleCentralizing prescreening data collection to inform data-driven approaches to clinical trial recruitment.
DOI:10.1186/s13195-023-01235-4 PMID: 37131229 -
Gierzynski TF, Gregoire A, Reader JM, Pantis R, Campbell S, Bhaumik A, Rahman-Filipiak A, Heidebrink J, Giordani B, Paulson H, Hampstead BM. Journal of the International Neuropsychological Society, 2023 Nov; 29 (1): 499 - 500.Journal Article97 Evaluation of Video and Telephone-Based Administration of the Uniform Data Set Version 3 (UDS v3.0) Teleneuropsychological Measures
-
Garcia S, Askew RL, Kavcic V, Shair S, Bhaumik AK, Rose E, Campbell S, May N, Hampstead BM, Dodge HH, Heidebrink JL, Paulson HL, Giordani B. Alzheimer Dis Assoc Disord, 2023 Oct; 37 (4): 328 - 334.Journal ArticleMild Cognitive Impairment Subtype Performance in Comparison to Healthy Older Controls on the NIH Toolbox and Cogstate.
DOI:10.1097/WAD.0000000000000587 PMID: 37862614
Department News
Changing the way an Alzheimer's drug is administered may make it more effective, experts say.
Department News
Tai chi may help boost cognitive health for seniors, a study has found.
Department News
Exciting news was released during the Alzheimer’s Association International Conference.
Department News
"First breakthrough" therapy for early onset Alzheimer's gets FDA approval
Department News
A promising Alzheimer’s therapy could soon get FDA approval.
